Related Experiment Videos
Susceptibility of Cryptococcus neoformans by the NCCLS microdilution and Etest methods using five defined media
1Department of Infectious Diseases and Microbiology, Imperial College School of Medicine, Hammersmith Campus, Du Cane Road, London, 1DA, UK. m.petrou@ic.ac.uk
The Journal of Antimicrobial Chemotherapy
|November 4, 2000
Summary
This study evaluated antifungal susceptibility testing for Cryptococcus neoformans. Yeast Nitrogen Base (YNB) pH 7.0 or RPMI MOPS with glucose are recommended media for reliable results.
Area of Science:
- Mycology
- Antimicrobial Susceptibility Testing
- Medical Mycology
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen.
- Antifungal resistance is a growing concern in treating cryptococcosis.
- Standardized susceptibility testing is crucial for guiding therapy.
Purpose of the Study:
- To compare the performance of different culture media and methods for antifungal susceptibility testing of Cryptococcus neoformans.
- To identify optimal conditions for reliable antifungal susceptibility testing of C. neoformans isolates.
Main Methods:
- Testing susceptibility of 12 C. neoformans isolates against five antifungal agents (amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, ketoconazole).
- Utilizing NCCLS and Etest methods.
- Evaluating various media: Yeast Nitrogen Base (YNB) at pH 5.6 and 7.0, RPMI MOPS at pH 7.0 (with and without 2% glucose), and RPMI buffered to pH 7.0.
Main Results:
- Poor growth observed in RPMI MOPS for some isolates after 72 hours.
- Yeast Nitrogen Base (YNB) pH 5.6 proved optimal for 5-fluorocytosine but unsuitable for ketoconazole.
- Both NCCLS and Etest methods showed variability depending on the medium used.
Conclusions:
- Yeast Nitrogen Base (YNB) pH 7.0 or RPMI MOPS with 2% glucose are suitable media for antifungal susceptibility testing of C. neoformans using either NCCLS or Etest methods.
- Careful selection of culture medium is essential for accurate antifungal susceptibility results.
- Further optimization of testing protocols may be needed for specific antifungal agents.